Search Results - "LANGMAN, Michael J. S"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Sudden death in patients receiving drugs tending to prolong the QT interval by Jolly, Kate, Gammage, Michael D., Cheng, Kar Keung, Bradburn, Peter, Banting, Miriam V., Langman, Michael J. S.

    Published in British journal of clinical pharmacology (01-11-2009)
    “…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Drugs slowing electocardiographic QT conduction can cause tachyarrhythmias, torsades de pointes (TdP) and cardiac…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Adverse effects of conventional non-steroidal anti-inflammatory drugs on the upper gastrointestinal tract by Langman, Michael J. S.

    Published in Fundamental & clinical pharmacology (01-08-2003)
    “…This article reviews the clinical and epidemiological features of conventional non‐steroidal anti‐inflammatory drug (NSAID) related peptic ulcer complications,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    NSAIDs and gastrointestinal cancer prevention by JOLLY, Kate, CHENG, Kar K, LANGMAN, Michael J. S

    Published in Drugs (New York, N.Y.) (2002)
    “…Numerous studies report the relationship between aspirin and other nonsteroidal anti-inflammatories (NSAIDs) and cancer incidence, in particular for colorectal…”
    Get full text
    Journal Article
  6. 6

    Loss of Estrogen Inactivation in Colonic Cancer by English, Mark A, Kane, Kate F, Cruickshank, Neil, Langman, Michael J. S, Stewart, Paul M, Hewison, Martin

    “…Age and sex differences in the incidence of colonic cancer, together with epidemiological data on patients taking hormone replacement therapy, suggest the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Heparin therapy for ulcerative colitis? Effects and mechanisms by MICHELL, Nicholas P, LALOR, Patricia, LANGMAN, Michael J. S

    “…Despite intensive medical treatment with steroids and immunosuppressants, acute colitis is still associated with a colectomy rate of up to 15%. Following the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Protein kinase C delta is not activated by caspase-3 and its inhibition is sufficient to induce apoptosis in the colon cancer line, COLO 205 by Lewis, Aurélia E., Susarla, Radhika, Wong, Benjamin C.Y., Langman, Michael J.S., Eggo, Margaret C.

    Published in Cellular signalling (01-02-2005)
    “…Activation of protein kinase C δ (PKCδ) is believed to be pro-apoptotic. PKCδ is reported to be reduced in colon cancers. Using a colon cancer cell line, COLO…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Protein kinase C inhibition induces DNA fragmentation in COLO 205 cells which is blocked by cysteine protease inhibition but not mediated through caspase-3 by Lewis, Aurélia E, Wong, Benjamin C.Y, Langman, Michael J.S, Eggo, Margaret C

    Published in Experimental cell research (10-09-2003)
    “…Enhancing apoptosis to remove abnormal cells has potential in reversing cancerous processes. Caspase-3 activation generally accompanies apoptosis and its…”
    Get full text
    Journal Article
  13. 13

    Targets of 17beta-oestradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy? by Qiu, Y, Langman, MJ, Eggo, MC

    Published in Journal of endocrinology (01-05-2004)
    “…Epidemiological studies show a strong link between postmenopausal hormone replacement therapy and decreased incidence of colorectal cancer. The colon cancer…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Expression of oestrogen receptor and oestrogen-inducible genes ps2 and erd5 in large bowel mucosa and cancer by Singh, Sukhdev, Poulsom, Richard, Hanby, Andrew M., Rogers, Len A., Wright, Nicholas A., Sheppard, Michael C., Langman, Michael J. S.

    Published in The Journal of pathology (01-02-1998)
    “…Since there is a preponderance of large bowel cancer in males, both in humans and in experimental models, and hormone replacement therapy is protective, a role…”
    Get full text
    Journal Article
  16. 16

    Smoking And Crohn's Disease by Somerville, Kevin W., Logan, Richard F. A., Edmond, Margaret, Langman, Michael J. S.

    “…In a case-control study 82 patients with Crohn's disease and matched controls drawn from general practice lists were questioned about their smoking habits…”
    Get full text
    Journal Article
  17. 17

    Safety of acid-suppressing drugs by SMALLWOOD, R. A, BERLIN, R. G, CASTAGNOLI, N, FESTEN, H. P. M, HAWKEY, C. J, LAM, S. K, LANGMAN, M. J. S, LUNDBORG, P, PARKINSON, A

    Published in Digestive diseases and sciences (01-02-1995)
    “…There is an extensive literature on the adverse effects of drugs that inhibit gastric acid secretion. This study presents a critical examination of…”
    Get full text
    Conference Proceeding Journal Article
  18. 18

    Smoking And Ulcerative Colitis by Logan, Richard F. A., Edmond, Margaret, Somerville, Kevin W., Langman, Michael J. S.

    “…In a case-control study of smoking and ulcerative colitis patients with the disease were much less likely to smoke than community controls matched for age and…”
    Get full text
    Journal Article
  19. 19

    Testing the efficacy of antisecretory drugs in patients with haematemesis and melaena by Langman, M J

    Published in Gastroenterologia Japonica (01-07-1991)
    “…Despite the logical expectation of effectiveness, and wide use, of antisecretory drugs in the initial management of patients with hematemesis and melaena,…”
    Get more information
    Journal Article
  20. 20